Why Do We Die of Cancer? A Brief Overview of the Pathophysiology of Cancer

Originally published online at https://arbonahealthhub.com/2024/11/26/why-do-we-die-of-cancer-a-brief-overview-of-the-pathophysiology-of-death-from-cancer/ This article provides an overview of how cancer leads to death by detailing the progression from unchecked cellular mutations to benign and malignant tumor formation, and the subsequent mechanisms—such as tissue hypoxia from vascular compression, organ parenchyma destruction, hemorrhage due to vessel invasion, and critical pathway obstruction, that compromise vital physiological functions. It also highlights how metastasis spreads cancer cells via the bloodstream or lymphatic system to distant organs, exacerbating organ failure, and discusses how standard treatments like chemotherapy, radiotherapy, and surgery, while targeting tumors, can further weaken the immune system and increase the risk of fatal infections or systemic inflammation. Together, these factors—tumor growth, metastasis, organ collapse, and treatment‐related complications—converge to precipitate the multisystem failure that ultimately results in death from cancer.

Institutions

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2024-11-26
DOI
https://doi.org/10.5281/zenodo.15977099
Primary Topic
Cancer Research and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Why Do We Die of Cancer? A Brief Overview of the Pathophysiology of Cancer

Zenodo (CERN European Organization for Nuclear Research)
Cancer Research and Treatments
article

Why Do We Die of Cancer? A Brief Overview of the Pathophysiology of Cancer

article en

Abstract

Originally published online at https://arbonahealthhub.com/2024/11/26/why-do-we-die-of-cancer-a-brief-overview-of-the-pathophysiology-of-death-from-cancer/ This article provides an overview of how cancer leads to death by detailing the progression from unchecked cellular mutations to benign and malignant tumor formation, and the subsequent mechanisms—such as tissue hypoxia from vascular compression, organ parenchyma destruction, hemorrhage due to vessel invasion, and critical pathway obstruction, that compromise vital physiological functions. It also highlights how metastasis spreads cancer cells via the bloodstream or lymphatic system to distant organs, exacerbating organ failure, and discusses how standard treatments like chemotherapy, radiotherapy, and surgery, while targeting tumors, can further weaken the immune system and increase the risk of fatal infections or systemic inflammation. Together, these factors—tumor growth, metastasis, organ collapse, and treatment‐related complications—converge to precipitate the multisystem failure that ultimately results in death from cancer.

Zenodo (CERN European Organization for Nuclear Research)
University of Puerto Rico System (PR)
Good health and well-being
Openalex Percentile: Top 66%
Cancer Research and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Why Do We Die of Cancer? A Brief Overview of the Pathophysiology of Cancer · Zenodo (CERN European Organization for Nuclear Research) (2024) | TGRS Research Map | TGRS